Endura Therapeutics is the RNA covalency company. Our small molecules form a permanent, enduring bond with an mRNA target, blocking translation and knocking down disease-causing proteins that conventional drugs can't reach. Gene-level precision like CRISPR, but in a pill.

Powered by a sequencing-based discovery platform that identifies druggable RNA targets empirically across the transcriptome, Endura is building a pipeline against the many disease-causing proteins that remain undrugged. Founded by a team from Novartis, Stanford, and the University of Toronto.

Endura Therapeutics

Org chart

Teams

Offices